Yaz Blood Clots

December 13, 2013

Important Information

ClassAction.org is no longer reviewing claims for this case. The information here is for reference only. Up-to-date information and resources can be found here.

Comments |

At A Glance

This Alert Affects
Women who have taken Yaz, Yasmin or Ocella birth control pills and experienced life threatening side effects, such as blood clots, heart attack, stroke, deep vein thrombosis (DVT), venous thromboembolism (VTE) or pulmonary embolism.
Damages
Yaz, Yasmin and Ocella side effects include heart attack, stroke, blood clots, deep vein thrombosis (DVT), venous thromboembolism (VTE), benign liver tumors, and gallbladder disease.
Company(ies)
Bayer Healthcare
Additional Details
Yaz, Yasmin, and the generic equivalent Ocella are once a day oral contraceptives that are designed to prevent pregnancy. Yaz has also been FDA-approved to treat Premenstrual Dysphoric Disorder (PMDD).
Date
In October 2011, the FDA announced that the risk of Yaz blood clots in users of Yaz and other drospirenone-containing pills was higher when compared to those taking older versions of the pill.